About Lytica Therapeutics
Lytica Therapeutics is a private company based in Cambridge, Massachusetts. It has reported $11,815,000 raised in three offerings on Form D since March 2024.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Feb 28, 2025 | Apr 11, 2025 | $6,000,000target not set | 17 | $352K | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Jul 3, 2024 | Aug 19, 2024 | $1,750,000target not set | 9 | $194K | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Feb 27, 2024 | Mar 12, 2024 | $4,065,000target not set | 14 | $290K | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Total, three offerings | $11,815,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Lytica Therapeutics's Form D filed Apr 11, 2025.
JD
Jean-Francois Ducrest
Director
JL
James Latorre
Director
DM
Daniel Macaya
Director
RM
Rida Mourtada
President and director